Amer Bio Medica Odds of Future Pink Sheet Price Finishing Over 0.0173
| ABMCDelisted Stock | USD 0.01 0 38.00% |
Amer |
Amer Bio Target Price Odds to finish over 0.0173
The tendency of Amer Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.02 or more in 90 days |
| 0.01 | 90 days | 0.02 | roughly 2.85 |
Based on a normal probability distribution, the odds of Amer Bio to move over $ 0.02 or more in 90 days from now is roughly 2.85 (This Amer Bio Medica probability density function shows the probability of Amer Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Amer Bio Medica price to stay between its current price of $ 0.01 and $ 0.02 at the end of the 90-day period is about 18.01 .
Given the investment horizon of 90 days Amer Bio Medica has a beta of -4.5. This suggests as returns on its benchmark rise, returns on holding Amer Bio Medica are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Amer Bio is expected to outperform its benchmark. In addition to that Amer Bio Medica has an alpha of 2.6633, implying that it can generate a 2.66 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Amer Bio Price Density |
| Price |
Predictive Modules for Amer Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amer Bio Medica. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amer Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Amer Bio is not an exception. The market had few large corrections towards the Amer Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amer Bio Medica, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amer Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.66 | |
β | Beta against Dow Jones | -4.5 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.10 |
Amer Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amer Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amer Bio Medica can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Amer Bio Medica is not yet fully synchronised with the market data | |
| Amer Bio Medica has some characteristics of a very speculative penny stock | |
| Amer Bio Medica has a very high chance of going through financial distress in the upcoming years | |
| Amer Bio Medica currently holds 1.53 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Amer Bio Medica has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amer Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Amer Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amer Bio Medica sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amer to invest in growth at high rates of return. When we think about Amer Bio's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.22 M. Net Loss for the year was (463 K) with profit before overhead, payroll, taxes, and interest of 548 K. | |
| Amer Bio Medica currently holds about 2 K in cash with (673 K) of positive cash flow from operations. | |
| Roughly 31.0% of Amer Bio shares are held by company insiders | |
| Latest headline from investing.com: Accel Entertainment director David Ruttenberg sells 288,705 in stock |
Amer Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amer Pink Sheet often depends not only on the future outlook of the current and potential Amer Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amer Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42.8 M | |
| Cash And Short Term Investments | 115 K |
Amer Bio Technical Analysis
Amer Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Amer Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Amer Bio Medica. In general, you should focus on analyzing Amer Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Amer Bio Predictive Forecast Models
Amer Bio's time-series forecasting models is one of many Amer Bio's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Amer Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Amer Bio Medica
Checking the ongoing alerts about Amer Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Amer Bio Medica help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Amer Bio Medica is not yet fully synchronised with the market data | |
| Amer Bio Medica has some characteristics of a very speculative penny stock | |
| Amer Bio Medica has a very high chance of going through financial distress in the upcoming years | |
| Amer Bio Medica currently holds 1.53 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Amer Bio Medica has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amer Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Amer Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amer Bio Medica sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amer to invest in growth at high rates of return. When we think about Amer Bio's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.22 M. Net Loss for the year was (463 K) with profit before overhead, payroll, taxes, and interest of 548 K. | |
| Amer Bio Medica currently holds about 2 K in cash with (673 K) of positive cash flow from operations. | |
| Roughly 31.0% of Amer Bio shares are held by company insiders | |
| Latest headline from investing.com: Accel Entertainment director David Ruttenberg sells 288,705 in stock |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Amer Pink Sheet
If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |